Stock Information
Intellia Therapeutics Inc (NTLA)
Ticker Symbol: NTLA
Exchange: NASDAQ
Sector: N/A
Market Cap: $1,031,603,574.00 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -4.2656
Revenue (TTM): $0.52 M
Dividend Yield: N/A%
ROE: -57.24%
Latest News
-
Alnylam Pharmaceuticals: Challenges In The TTR Space And Few Late-Stage Catalysts Are A Concern
Sat, Dec 13, 2025 10:45 PM
Key Financials
Financial data not available